Skip to main content
. 2018 Mar 20;16:74. doi: 10.1186/s12967-018-1436-4

Fig. 6.

Fig. 6

Immunohistochemistry analysis of asthma models treated with OVA, OX40L-Ig fusion protein and anti-mouse-OX40L mAb. More significantly increased inflammatory cells infiltration and expression of OX40L in OVA + OX40L, and infiltration of eosinophils in the lung tissue was markedly decreased in OVA + anti-OX40L